The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac).

Please click here to read the rest of the FDA News Release.

Media Coverage Below:

Apotheke Adhoc (Germany):  USA: Ranitidin muss komplett zurück